About Quanterix
Quanterix is poised to transform healthcare through its groundbreaking biomarker detection technology. Our mission is to empower researchers with advanced tools to investigate the continuum of health and disease, facilitating earlier diagnosis and treatment. Through our proprietary Simoa® technology, we offer unparalleled sensitivity in biomarker quantification that enables critical insights into various health conditions.
Founded in 2007 and based in Billerica, Massachusetts, Quanterix has established itself as a leader in the precision health space. Our solutions are vital for research in therapeutic areas such as oncology, neurology, cardiology, inflammation, and infectious disease. The Simoa platforms and assay kits we provide incorporate innovative advancements that support scientists in their quest for understanding and combating diseases more effectively.
FAQs
- Which countries does Quanterix have remote employees in?
- Quanterix has employees in United States.
- When was Quanterix founded?
- Quanterix was founded in 2007.
- Who is the CEO of Quanterix?
- Masoud Toloue is the CEO of Quanterix.
- How many employees does Quanterix have?
- Quanterix has 201-500 employees.
- What industries or markets does Quanterix operate in?
- Quanterix operates in the following markets: Healthcare Technology, Precision Medicine, Diagnostics, Medical Devices, Life Sciences, Oncology Research, Neurology Research, Cardiology Research, Infectious Disease Research, and Biotech.
- What is Quanterix's website?
- Quanterix's website is quanterix.com.